Insider sale
NEWAMSTERDAM PHARMA CO N.V.
$5.91M
303.20K shares
What this filing means
NAP POOLCO B.V. plans to sell 303.20K shares of NEWAMSTERDAM PHARMA CO N.V. valued at approximately $5.91M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/18/2025ACC: 0001470831-25-000050
303.20K
Shares to sell
$5.91M
Approx. market value
303.20K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Conversion of Contingent Value Rights
Conversion of Contingent Value Rights
3/25/2025
303.20KTotal acquired303.20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/25/2025 | Conversion of Contingent Value Rights Conversion of Contingent Value Rights | 303.20K | — |
| Total | 303.20K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
303.20K
Market value
$5.91M
6/16/2025
Total
Units
303.20K
Value
$5.91M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/16/2025 | 303.20K | $5.91M | Nasdaq | Planned |
| Total | 303.20K | $5.91M | ||